iRhythm Technologies Inc
IRTC188.300USD
+5.090+2.78%
Cierre 11/25, 16:00（ET）Cotizaciones retrasadas 15 min
6.06BCap. mercado
PérdidaP/E TTM
Más Datos de iRhythm Technologies Inc Compañía
iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
Información de iRhythm Technologies Inc
Símbolo de cotizaciónIRTC
Nombre de la empresaiRhythm Technologies Inc
Fecha de salida a bolsaOct 20, 2016
Director ejecutivoMr. Quentin S. Blackford
Número de empleados2000
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 20
Dirección699 8th Street
CiudadSAN FRANCISCO
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94103
Teléfono14156325700
Sitio Webhttps://www.irhythmtech.com/
Símbolo de cotizaciónIRTC
Fecha de salida a bolsaOct 20, 2016
Director ejecutivoMr. Quentin S. Blackford
Ejecutivos de iRhythm Technologies Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Quentin S. Blackford
Mr. Quentin S. Blackford
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
63.30K
-18.17%
Ms. Sumi Shrishrimal
Ms. Sumi Shrishrimal
Executive Vice President, Chief Risk Officer
Executive Vice President, Chief Risk Officer
33.78K
-1.90%
Mr. Abhijit Y. (Abhi) Talwalkar
Mr. Abhijit Y. (Abhi) Talwalkar
Independent Chairman of the Board
Independent Chairman of the Board
18.46K
--
Mr. Mervin Smith
Mr. Mervin Smith
Executive Vice President - Business Operations
Executive Vice President - Business Operations
15.84K
-3.74%
Dr. Minang (Mintu) Turakhia, M.D.
Dr. Minang (Mintu) Turakhia, M.D.
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
12.56K
-10.16%
Dr. Ralph Snyderman, M.D.
Dr. Ralph Snyderman, M.D.
Independent Director
Independent Director
11.45K
+13.46%
Mr. Bruce G. Bodaken
Mr. Bruce G. Bodaken
Independent Director
Independent Director
10.80K
+14.39%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
7.73K
+21.32%
Mr. Daniel G. (Dan) Wilson
Mr. Daniel G. (Dan) Wilson
Chief Financial Officer
Chief Financial Officer
3.96K
-66.88%
Ms. Karen K. Mcginnis, CPA
Ms. Karen K. Mcginnis, CPA
Independent Director
Independent Director
2.04K
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Quentin S. Blackford
Mr. Quentin S. Blackford
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
63.30K
-18.17%
Ms. Sumi Shrishrimal
Ms. Sumi Shrishrimal
Executive Vice President, Chief Risk Officer
Executive Vice President, Chief Risk Officer
33.78K
-1.90%
Mr. Abhijit Y. (Abhi) Talwalkar
Mr. Abhijit Y. (Abhi) Talwalkar
Independent Chairman of the Board
Independent Chairman of the Board
18.46K
--
Mr. Mervin Smith
Mr. Mervin Smith
Executive Vice President - Business Operations
Executive Vice President - Business Operations
15.84K
-3.74%
Dr. Minang (Mintu) Turakhia, M.D.
Dr. Minang (Mintu) Turakhia, M.D.
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
12.56K
-10.16%
Dr. Ralph Snyderman, M.D.
Dr. Ralph Snyderman, M.D.
Independent Director
Independent Director
11.45K
+13.46%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Commercial Payors
97.72M
52.34%
Contracted third-party payors
97.72M
52.34%
Centers for Medicare & Medicaid
44.48M
23.83%
Healthcare Institutions
31.83M
17.05%
Non-contracted third-party payors
12.66M
6.78%
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Commercial Payors
97.72M
52.34%
Contracted third-party payors
97.72M
52.34%
Centers for Medicare & Medicaid
44.48M
23.83%
Healthcare Institutions
31.83M
17.05%
Non-contracted third-party payors
12.66M
6.78%
Estadísticas de accionistas
Actualizado: mar., 18 de nov
Actualizado: mar., 18 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
10.03%
Artisan Partners Limited Partnership
7.97%
BlackRock Institutional Trust Company, N.A.
7.35%
Sands Capital Management, LLC
6.94%
Capital Research Global Investors
3.67%
Otro
64.04%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
10.03%
Artisan Partners Limited Partnership
7.97%
BlackRock Institutional Trust Company, N.A.
7.35%
Sands Capital Management, LLC
6.94%
Capital Research Global Investors
3.67%
Otro
64.04%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
66.24%
Investment Advisor/Hedge Fund
28.39%
Hedge Fund
10.19%
Research Firm
5.20%
Family Office
1.35%
Individual Investor
1.02%
Pension Fund
0.97%
Sovereign Wealth Fund
0.71%
Bank and Trust
0.54%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
609
36.08M
112.00%
-5.27M
2025Q2
586
36.46M
113.50%
-2.59M
2025Q1
586
36.68M
114.94%
-2.13M
2024Q4
571
35.12M
111.82%
-4.41M
2024Q3
584
35.86M
114.62%
-4.91M
2024Q2
581
36.60M
117.28%
-2.20M
2024Q1
578
35.68M
114.75%
-1.24M
2023Q4
542
34.05M
110.03%
-1.99M
2023Q3
543
34.13M
111.64%
-2.86M
2023Q2
537
34.27M
112.49%
-3.29M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
3.23M
10.05%
+127.22K
+4.10%
Jun 30, 2025
Artisan Partners Limited Partnership
2.74M
8.53%
-73.44K
-2.61%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.33M
7.25%
-18.29K
-0.78%
Jun 30, 2025
Sands Capital Management, LLC
2.92M
9.07%
-100.68K
-3.34%
Jun 30, 2025
Capital Research Global Investors
1.51M
4.69%
-695.76K
-31.59%
Jun 30, 2025
Capital World Investors
1.44M
4.47%
+247.00
+0.02%
Aug 31, 2025
State Street Investment Management (US)
868.52K
2.7%
-49.16K
-5.36%
Jun 30, 2025
Geode Capital Management, L.L.C.
767.34K
2.39%
+16.97K
+2.26%
Jun 30, 2025
William Blair & Company, L.L.C. (Research)
739.33K
2.3%
-50.67K
-6.41%
Jun 30, 2025
Eventide Asset Management, LLC
691.57K
2.15%
-48.49K
-6.55%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: dom., 2 de nov
Actualizado: dom., 2 de nov
Nombre
Proporción
Global X HealthTech ETF
4.9%
Fidelity Digital Health ETF
2.4%
First Trust Nasdaq Lux Digi Health Solutions ETF
1.9%
Invesco Dorsey Wright Healthcare Momentum ETF
1.72%
ROBO Global Healthcare Technology & Innovation ETF
1.56%
SPDR S&P Health Care Equipment ETF
1.55%
Langar Global HealthTech ETF
1.52%
Goldman Sachs Future Health Care Equity ETF
1.49%
First Trust Multi-Manager Small Cap Opportunities ETF
1.13%
Inspire Fidelis Multi Factor ETF
1.03%
Ver más
Global X HealthTech ETF
Proporción4.9%
Fidelity Digital Health ETF
Proporción2.4%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción1.9%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporción1.72%
ROBO Global Healthcare Technology & Innovation ETF
Proporción1.56%
SPDR S&P Health Care Equipment ETF
Proporción1.55%
Langar Global HealthTech ETF
Proporción1.52%
Goldman Sachs Future Health Care Equity ETF
Proporción1.49%
First Trust Multi-Manager Small Cap Opportunities ETF
Proporción1.13%
Inspire Fidelis Multi Factor ETF
Proporción1.03%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de iRhythm Technologies Inc?
Los cinco principales accionistas de iRhythm Technologies Inc son:
The Vanguard Group, Inc. posee 3.23M acciones, lo que representa el 10.05% del total de acciones.
Artisan Partners Limited Partnership posee 2.74M acciones, lo que representa el 8.53% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 2.33M acciones, lo que representa el 7.25% del total de acciones.
Sands Capital Management, LLC posee 2.92M acciones, lo que representa el 9.07% del total de acciones.
Capital Research Global Investors posee 1.51M acciones, lo que representa el 4.69% del total de acciones.
The Vanguard Group, Inc. posee 3.23M acciones, lo que representa el 10.05% del total de acciones.
Artisan Partners Limited Partnership posee 2.74M acciones, lo que representa el 8.53% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 2.33M acciones, lo que representa el 7.25% del total de acciones.
Sands Capital Management, LLC posee 2.92M acciones, lo que representa el 9.07% del total de acciones.
Capital Research Global Investors posee 1.51M acciones, lo que representa el 4.69% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de iRhythm Technologies Inc?
Los tres principales tipos de accionista de iRhythm Technologies Inc son:
The Vanguard Group, Inc.
Artisan Partners Limited Partnership
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Artisan Partners Limited Partnership
BlackRock Institutional Trust Company, N.A.
¿Cuántas instituciones poseen acciones de iRhythm Technologies Inc (IRTC)?
A fecha de 2025Q3, 609 instituciones poseen acciones de iRhythm Technologies Inc, con un valor de mercado combinado de aproximadamente 36.08M, lo que representa el 112.00% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en -1.50%.
¿Cuál es la mayor fuente de ganancias de iRhythm Technologies Inc?
El FY2025Q2, el segmento empresarial Commercial Payors generó la ganancia más alta para iRhythm Technologies Inc, ascendiendo a 97.72M y representando el 52.34% de la ganancia total.
